Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 8 studies | 33% ± 13% | |
abnormal cell | 3 studies | 20% ± 2% |
Insufficient scRNA-seq data for expression of ENPP3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 402.51 | 89 / 89 | 82% | 164.32 | 738 / 901 |
prostate | 99% | 414.66 | 243 / 245 | 51% | 5.92 | 255 / 502 |
intestine | 94% | 436.11 | 912 / 966 | 44% | 10.67 | 234 / 527 |
stomach | 91% | 71.13 | 326 / 359 | 34% | 8.62 | 97 / 286 |
liver | 92% | 149.89 | 207 / 226 | 29% | 3.64 | 116 / 406 |
adrenal gland | 100% | 817.21 | 258 / 258 | 20% | 4.49 | 46 / 230 |
lung | 93% | 89.53 | 536 / 578 | 25% | 4.47 | 285 / 1155 |
thymus | 92% | 64.29 | 601 / 653 | 23% | 7.55 | 140 / 605 |
breast | 97% | 122.91 | 443 / 459 | 16% | 3.08 | 179 / 1118 |
bladder | 90% | 63.29 | 19 / 21 | 20% | 3.99 | 102 / 504 |
uterus | 98% | 189.48 | 167 / 170 | 11% | 2.75 | 49 / 459 |
ovary | 96% | 103.83 | 172 / 180 | 11% | 1.37 | 49 / 430 |
adipose | 97% | 112.60 | 1169 / 1204 | 0% | 0 | 0 / 0 |
spleen | 97% | 63.59 | 233 / 241 | 0% | 0 | 0 / 0 |
brain | 88% | 78.07 | 2317 / 2642 | 0% | 0.02 | 3 / 705 |
esophagus | 81% | 63.01 | 1167 / 1445 | 2% | 0.21 | 4 / 183 |
blood vessel | 79% | 43.41 | 1048 / 1335 | 0% | 0 | 0 / 0 |
skin | 70% | 67.86 | 1272 / 1809 | 1% | 0.04 | 5 / 472 |
heart | 30% | 11.36 | 262 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 24% | 5.62 | 7 / 29 |
muscle | 18% | 5.92 | 144 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 17% | 8.45 | 162 / 929 | 0% | 0 | 0 / 0 |
pancreas | 13% | 3.82 | 41 / 328 | 2% | 0.08 | 3 / 178 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.23 | 2 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0055062 | Biological process | phosphate ion homeostasis |
GO_0006220 | Biological process | pyrimidine nucleotide metabolic process |
GO_0033007 | Biological process | negative regulation of mast cell activation involved in immune response |
GO_0070667 | Biological process | negative regulation of mast cell proliferation |
GO_0006796 | Biological process | phosphate-containing compound metabolic process |
GO_0046034 | Biological process | ATP metabolic process |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0030505 | Biological process | inorganic diphosphate transport |
GO_0009143 | Biological process | nucleoside triphosphate catabolic process |
GO_0002276 | Biological process | basophil activation involved in immune response |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
GO_0047710 | Molecular function | bis(5'-adenosyl)-triphosphatase activity |
GO_0003676 | Molecular function | nucleic acid binding |
GO_0034432 | Molecular function | bis(5'-adenosyl)-pentaphosphatase activity |
GO_0004528 | Molecular function | phosphodiesterase I activity |
GO_0004081 | Molecular function | bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity |
GO_0047429 | Molecular function | nucleoside triphosphate diphosphatase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005509 | Molecular function | calcium ion binding |
Gene name | ENPP3 |
Protein name | Ectonucleotide pyrophosphatase/phosphodiesterase 3 Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (EC 3.1.4.1) (EC 3.6.1.9) (Phosphodiesterase I beta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) DJ334I18.1 (Ectonucleotide pyrophosphatase/phosphodiesterase 3) Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (NPP3) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c) [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)] |
Synonyms | PDNP3 |
Description | FUNCTION: Hydrolase that metabolizes extracellular nucleotides, including ATP, GTP, UTP and CTP . Limits mast cell and basophil responses during inflammation and during the chronic phases of allergic responses by eliminating the extracellular ATP that functions as signaling molecule and activates basophils and mast cells and induces the release of inflammatory cytokines. Metabolizes extracellular ATP in the lumen of the small intestine, and thereby prevents ATP-induced apoptosis of intestinal plasmacytoid dendritic cells (By similarity). Has also alkaline phosphodiesterase activity . . |
Accessions | ENST00000357639.8 ENST00000423831.5 O14638 F8W6H5 E7ETI7 E9PDB4 ENST00000414305.5 ENST00000427707.5 ENST00000358229.6 Q9H515 |